For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Diabetic Wounds Market By Product Type (Wound Care Dressings [Foam Dressings, Antimicrobial Dressings, Hydrogel Dressings, Alginate Dressings, Silver Dressings, Hydrocolloid Dressings, Hydro Fiber Dressings, Others], Wound Care Devices [Negative Pressure Wound Therapy Devices, Hyperbaric & Oxygen Therapy Devices, Debridement Devices, Others], Skin Grafts & Substitutes, Growth Factors, Others), By Wound Type (Neuropathic Ulcer Wounds, Ischemic Ulcer Wounds, Neuro-Ischemic Ulcer Wounds), By End-User (Hospitals, Specialty Clinics, Others), by geography is expected to grow at a steady CAGR forecast till 2027 owing to the rising prevalence of diabetes, increase in diabetic foot ulcers among the population
Global Diabetic Wounds Market was valued at USD 2.22 Billion in 2021, growing at a CAGR of 7.48% during the forecast period from 2022 to 2027 to reach USD 3.44 Billion by 2027. The Diabetic Wounds market is witnessing positive growth owing to the rising prevalence of diabetes, increase in diabetic foot ulcers among the population, launch of novel active therapies, a surge in the number of amputations due to diabetic foot ulcers, thereby contributing to the growth of the Diabetic Wounds market during the forecast period from 2022-2027.
Diabetic Wounds Market Dynamics:
The rising Prevalence of Diabetes among the population across the globe is likely to increase the demand for diabetic wound treatment therapies and associated devices. This is because uncontrolled diabetes mellitus can lead to the development of diabetic wounds especially diabetic foot ulcers among the population.
For instance, according to the International Diabetes Federation 2019 report, approximately 463 million adults were suffering from diabetes in the year 2019 and it was estimated to rise to 700 million by the year 2045. Thus, rising diabetes cases could be a potential risk for developing diabetic wounds thereby increasing the need for treatment devices.
Moreover, rising diabetes cases in the low and middle-income countries could also be a factor that could lead to diabetic wounds in the patient in these regions ultimately leading to market growth.
According to the study: The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680?102 adults by Flood D. et al. published in the LANCET 2021, approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries.
Rising old age population, sedentary lifestyle, increase in obesity, and other factors that are potential risk factors for diabetes could also increase the risk for diabetic associated disorders such as diabetic wounds.
Therefore the above-mentioned factors will contribute to the market growth for diabetic wounds treatment therapy during the forecasted period.
However, the high cost of ulcer management and stringent regulations of the treatment devices may be certain limiting factors of the Diabetic Wounds market growth.
The ongoing COVID-19 pandemic has impacted the market for Diabetic Wound. This is because healthcare systems across the globe are facing tough challenges in delivering diabetic foot services to patients. Moreover, social distancing and shielding public health guidelines have also impacted diabetic foot treatment services delivery.
Diabetic Wounds Market Segment Analysis:
Diabetic Wounds Market By Product Type (Wound Care Dressings [Foam Dressings, Antimicrobial Dressings, Hydrogel Dressings, Alginate Dressings, Silver Dressings, Hydrocolloid Dressings, Hydro fiber Dressings, Others], Wound Care Devices [Negative Pressure Wound Therapy Devices, Hyperbaric & Oxygen Therapy Devices, Debridement Devices, Others], Skin Grafts & Substitutes, Growth factors, Others), By Wound Type (Neuropathic Ulcer Wounds, Ischemic Ulcer Wounds, Neuro-Ischemic Ulcer Wounds), By End-User (Hospitals, Specialty Clinics, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Product Type segment of the Diabetic Wounds market, Foam Dressings are estimated to hold a higher share in the Diabetic Wounds market during the forecast period (2022-2027). Availability of a variety of foam dressings such as adhesive borders, silicone borders, with variable pore sizes from (small, medium, and large) is likely to boost the market for foam dressing during the forthcoming years.
Moreover, ongoing research studies on foam dressings and positive results out of those studies will also contribute to the market growth of the foam dressings.
For instance, in March 2021, Smith+Nephew announced positive results from a real-world study from Spain that showed how a switch to ALLEVYN LIFE Foam Dressings helped to significantly reduce dressing change frequency and weekly dressing costs while improving treatment satisfaction for clinicians and patients in a community setting.
Furthermore, recent product approval in the product line is also a factor that could lead to the market growth of foam dressings.
For instance, on May 14, 2020, Winner Medical Co., Ltd., a medical and health company based in China received FDA approval for PHMB Foam Dressing Non-Adhesive, PHMB Foam Dressing Adhesive, Silicone PHMB Foam Dressing, and Silicone PHMB Foam Dressing with Border indicated for use in the management of post-surgical incisions, pressure sores, venous stasis ulcers, diabetic ulcers, among other chronic and acute wounds.
Hence all the factors will augment the market for foam dressings during the forthcoming period.
North America is expected to dominate the overall Diabetic Wounds Market:
Among all the regions, North America is expected to account for the largest share in the Global Diabetic Wounds market. The rise in the prevalence of diabetic foot ulcers in the North America region is likely to bolster the market for diabetic wound treatment in the region.
According to an article, Epidemiology and Burden of Diabetic Foot Ulcer and Peripheral Arterial Disease in Korea by Chun D.I. et al., published in the NCBI 2019, the prevalence of DFU (diabetic foot ulcer) in North America was approximately 13% of the overall global DFU prevalence.
Also, the rising burden of diabetes could be a potential risk factor for DFU in the region. As per the National Statistics Diabetes 2020 report, approximately 34.2 million Americans are suffering from diabetes.
In addition, the presence of key players such as 3M company, Coloplast, Cardinal Health, among others in the region is anticipated to boost the market for the Diabetic wound in the region.
Furthermore, the launch of programs by leading wound care expert companies will also contribute to the diabetic wound market growth in the region.
For instance, in January 2021, Healogics® launched a program to make 2021 the Year of Healing for the patients and for people struggling with a wound that will not heal. The program is dedicated to empowering both patients and healthcare providers with resources to help improve health, heal wounds and prevent unnecessary amputations.
Thus, all the aforementioned factors are going to fuel the market for diabetic wounds in the region.
Diabetic Wounds Market Key Players:
Some of the key market players operating in the Diabetic Wounds market include B Braun Meslungen AG, MEDCu, 3M, Integra LifeSciences., Organogenesis Inc, Bharat Biotech, RLS Global, Coloplast Corp, ConvaTec Inc., Cardinal Health, BSN medical Inc, HARTMANN USA, Inc, Mil Laboratories, Hollister Incorporated, DermaRite Industries, LLC, Mölnlycke Health Care AB, Osiris (Smith&Nephew), Lohmann & Rauscher, Medela AG, DeRoyal and others.
Recent Developmental Activities in the Diabetic Wounds Market:
- In April 2021, Joerns Healthcare and Medela announced a nationwide partnership to develop access to innovative negative pressure wound therapy systems. Through this agreement, Joerns will expand its wound care portfolio to include the full Medela line of negative pressure wound therapy products, including the Invia Liberty and Invia Motion 60 NPWT Systems.
- In June 2019, 3M acquired Acelity L.P. Inc. for $6.7 billion to enhance its strategy for advanced wound care solutions and accelerate the penetration of NPWT products internationally.
Key Takeaways from the Diabetic Wounds Market Report Study
- Market size analysis for current Diabetic Wounds market size (2020), and market forecast for 5 years (2022-2027)
- The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Diabetic Wounds market.
- Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
- Key companies dominating the global Diabetic Wounds market.
- Various opportunities available for the other competitor in the Diabetic Wounds market space.
- What are the top performing segments in 2020? How these segments will perform in 2026.
- Which is the top-performing regions and countries in the current Diabetic Wounds market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for Diabetic Wounds market growth in the coming future?
Target Audience who can be benefited from this Diabetic Wounds Market Report Study
- Diabetic Wounds products providers
- Research organizations and consulting companies
- Diabetic Wounds-related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and Traders dealing in Diabetic Wounds
- Various End-users who want to know more about the Diabetic Wounds market and latest technological developments in the Diabetic Wounds market.
Frequently Asked Questions for the Diabetic Wounds Market:
1. What are Diabetic Wounds?
Wounds can develop anywhere on the body, but diabetics are most vulnerable to cuts, scrapes, and sores on their lower extremities. When a person has diabetes, wounds can take longer to heal, which can increase the risk of infections and other complications developing.
2. What is the market for Global Diabetic Wounds?
Global Diabetic Wounds Market was valued at USD 2.22 Billion in 2021, growing at a CAGR of 7.48% during the forecast period from 2022 to 2027 to reach USD 3.44 Billion by 2027.
3. What are the drivers for the Global Diabetic Wounds Market?
The Diabetic Wounds market is witnessing a positive market growth owing to the rising prevalence of diabetes, increase in diabetic foot ulcers among the population, the launch of novel active therapies, a surge in the number of amputations due to diabetic foot ulcers, thereby contributing to the growth of the Diabetic Wounds market during the forecast period from 2022-2027
4. Who are the key players operating in the Global Diabetic Wounds Market?
Some of the key market players operating in the Diabetic Wounds market include B Braun Meslungen AG, MEDCu, 3M, Integra LifeSciences., Organogenesis Inc, Bharat Biotech, RLS Global, Coloplast Corp, ConvaTec Inc., Cardinal Health, BSN medical Inc, HARTMANN USA, Inc, Mil Laboratories, Hollister Incorporated, DermaRite Industries, LLC, Mölnlycke Health Care AB, Osiris (Smith&Nephew), Lohmann & Rauscher, Medela AG, DeRoyal, and others.
5. Which region has the highest share in the Diabetic Wounds Market?
North America is expected to hold the highest share in the revenue in the Diabetic Wounds market during the forecast period. The rise in the prevalence of diabetic foot ulcers in the North America region is likely to bolster the market for diabetic wound treatment in the region.